Download PDF
Semin intervent Radiol 2011; 28(3): 325-332
DOI: 10.1055/s-0031-1284459
© Thieme Medical Publishers

Balloon-occluded Retrograde Transvenous Obliteration (BRTO): Follow-Up and Postprocedural Imaging

Brian G. Sauer1 , Saher S. Sabri2 , Vanessa M. Shami1 , Abdullah M. S. Al-Osaimi1
  • 1Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia Health System, Charlottesville, Virginia
  • 2Division of Vascular Interventional Radiology, Department of Radiology, University of Virginia Health System, Charlottesville, Virginia
Further Information

Publication History

Publication Date:
15 August 2011 (online)

Also available at
    Permissions and Reprints

ABSTRACT

The majority of patients undergoing balloon retrograde transvenous obliteration (BRTO) are decompensated cirrhotic for either bleeding gastric varices (GV) or hepatic encephalopathy. These patients will require close follow-up and assessments pre- and post-BRTO including clinical, laboratory, endoscopic, and imaging evaluations. It is essential that clinicians are aware of the potential benefits and complications that may result from BRTO. These complications may include fever, chest or epigastric pain, hemoglobinuria, transient hypertension, nausea or vomiting, and many more. These complications usually resolve within the first 10 days. Laboratory abnormalities are transient and uncommon. Radiologic and endoscopic follow-up are required including computed tomography (CT), magnetic resonance imaging (MRI), routine upper endoscopy and endoscopic ultrasound (EUS), which are detailed in this review. Patients undergoing BRTO are usually complicated and will require a team approach. This team should include the hepatologist, endoscopist, and interventional radiologist. Understanding and open dialogue are essential in the management of post-BRTO patients. The authors review the possible benefits, potential complications, and the evaluation tools needed to improve outcomes.

KEYWORDS

Gastric varices - portal hypertension - liver cirrhosis - BRTO - TIPS - splenorenal shunt - EUS

REFERENCES

  • 1 Kanagawa H, Mima S, Kouyama H, Gotoh K, Uchida T, Okuda K. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration.  J Gastroenterol Hepatol. 1996;  11 (1) 51-58
    CrossrefPubMedGoogle Scholar
  • 2 Koito K, Namieno T, Nagakawa T, Morita K. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals.  AJR Am J Roentgenol. 1996;  167 (5) 1317-1320
    CrossrefPubMedGoogle Scholar
  • 3 Kitamoto M, Imamura M, Kamada K et al.. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage.  AJR Am J Roentgenol. 2002;  178 (5) 1167-1174
    CrossrefPubMedGoogle Scholar
  • 4 Sakurabayashi S, Sezai S, Yamamoto Y, Hirano M, Oka H. Embolization of portal-systemic shunts in cirrhotic patients with chronic recurrent hepatic encephalopathy.  Cardiovasc Intervent Radiol. 1997;  20 (2) 120-124
    CrossrefPubMedGoogle Scholar
  • 5 Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy.  J Vasc Interv Radiol. 2001;  12 (3) 327-336
    CrossrefPubMedGoogle Scholar
  • 6 Tanabe N, Ishii M, Sato Y et al.. Effects of collateral vessel occlusion on oral glucose tolerance test in liver cirrhosis.  Dig Dis Sci. 2000;  45 (3) 581-586
    CrossrefPubMedGoogle Scholar
  • 7 Kumamoto M, Toyonaga A, Inoue H et al.. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome.  J Gastroenterol Hepatol. 2010;  25 (6) 1129-1135
    CrossrefPubMedGoogle Scholar
  • 8 Takuma Y, Nouso K, Makino Y, Saito S, Shiratori Y. Prophylactic balloon-occluded retrograde transvenous obliteration for gastric varices in compensated cirrhosis.  Clin Gastroenterol Hepatol. 2005;  3 (12) 1245-1252
    CrossrefPubMedGoogle Scholar
  • 9 Nakano R, Iwao T, Oho K, Toyonaga A, Tanikawa K. Splanchnic hemodynamic pattern and liver function in patients with cirrhosis and esophageal or gastric varices.  Am J Gastroenterol. 1997;  92 (11) 2085-2089
    PubMedGoogle Scholar
  • 10 Choi Y H, Yoon C J, Park J H, Chung J W, Kwon J W, Choi G M. Balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding: its feasibility compared with transjugular intrahepatic portosystemic shunt.  Korean J Radiol. 2003;  4 (2) 109-116
    CrossrefPubMedGoogle Scholar
  • 11 Kato T, Uematsu T, Nishigaki Y, Sugihara J, Tomita E, Moriwaki H. Therapeutic effect of balloon-occluded retrograde transvenous obliteration on portal-systemic encephalopathy in patients with liver cirrhosis.  Intern Med. 2001;  40 (8) 688-691
    CrossrefPubMedGoogle Scholar
  • 12 Akahane T, Iwasaki T, Kobayashi N et al.. Changes in liver function parameters after occlusion of gastrorenal shunts with balloon-occluded retrograde transvenous obliteration.  Am J Gastroenterol. 1997;  92 (6) 1026-1030
    PubMedGoogle Scholar
  • 13 Miyamoto Y, Oho K, Kumamoto M, Toyonaga A, Sata M. Balloon-occluded retrograde transvenous obliteration improves liver function in patients with cirrhosis and portal hypertension.  J Gastroenterol Hepatol. 2003;  18 (8) 934-942
    CrossrefPubMedGoogle Scholar
  • 14 Cardoso J E, Gautreau C, Jeyaraj P R et al.. Augmentation of portal blood flow improves function of human cirrhotic liver.  Hepatology. 1994;  19 (2) 375-380
    CrossrefPubMedGoogle Scholar
  • 15 Saad W, Darwish W, Anderson  et al.. The effect of balloon-occluded retrograde transvenous obliteration (BRTO) on the model of end-stage liver disease (MELD) score.  J Vasc Interv Radiol. 2011;  22 (35) S34-35 (Abst.)
    PubMedGoogle Scholar
  • 16 Shimoda R, Horiuchi K, Hagiwara S et al.. Short-term complications of retrograde transvenous obliteration of gastric varices in patients with portal hypertension: effects of obliteration of major portosystemic shunts.  Abdom Imaging. 2005;  30 (3) 306-313
    CrossrefPubMedGoogle Scholar
  • 17 Wada H, Hashizume M, Yamaga H, Kitano S, Sugimachi K. Hemodynamic and morphological changes in the dog kidney after injection of 5% ethanolamine oleate into the superior vena cava.  Eur Surg Res. 1990;  22 (2) 63-70
    CrossrefPubMedGoogle Scholar
  • 18 Hiraga N, Aikata H, Takaki S et al.. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration.  J Gastroenterol. 2007;  42 (8) 663-672
    CrossrefPubMedGoogle Scholar
  • 19 Sabri S S, Swee W, Turba U C et al.. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam.  J Vasc Interv Radiol. 2011;  22 (3) 309-316 quiz 316
    CrossrefPubMedGoogle Scholar
  • 20 McCormack T, Martin T, Smallwood R H, Robinson P, Walton L, Johnson A G. Doppler ultrasound probe for assessment of blood-flow in oesophageal varices.  Lancet. 1983;  1 (8326 Pt 1) 677-678
    PubMedGoogle Scholar
  • 21 Caletti G C, Bolondi L, Zani L, Brocchi E, Guizzardi G, Labò G. Detection of portal hypertension and esophageal varices by means of endoscopic ultrasonography.  Scand J Gastroenterol Suppl. 1986;  123 74-77
    PubMedGoogle Scholar
  • 22 Burtin P, Calès P, Oberti F et al.. Endoscopic ultrasonographic signs of portal hypertension in cirrhosis.  Gastrointest Endosc. 1996;  44 (3) 257-261
    CrossrefPubMedGoogle Scholar
  • 23 Caletti G, Brocchi E, Baraldini M, Ferrari A, Gibilaro M, Barbara L. Assessment of portal hypertension by endoscopic ultrasonography.  Gastrointest Endosc. 1990;  36 (2, Suppl) S21-S27
    CrossrefPubMedGoogle Scholar
  • 24 Choudhuri G, Dhiman R K, Agarwal D K. Endosonographic evaluation of the venous anatomy around the gastro-esophageal junction in patients with portal hypertension.  Hepatogastroenterology. 1996;  43 (11) 1250-1255
    PubMedGoogle Scholar
  • 25 Iwase H, Suga S, Morise K, Kuroiwa A, Yamaguchi T, Horiuchi Y. Color Doppler endoscopic ultrasonography for the evaluation of gastric varices and endoscopic obliteration with cyanoacrylate glue.  Gastrointest Endosc. 1995;  41 (2) 150-154
    CrossrefPubMedGoogle Scholar
  • 26 Konishi Y, Nakamura T, Kida H, Seno H, Okazaki K, Chiba T. Catheter US probe EUS evaluation of gastric cardia and perigastric vascular structures to predict esophageal variceal recurrence.  Gastrointest Endosc. 2002;  55 (2) 197-203
    CrossrefPubMedGoogle Scholar
  • 27 Lo G H, Lai K H, Cheng J S, Huang R L, Wang S J, Chiang H T. Prevalence of paraesophageal varices and gastric varices in patients achieving variceal obliteration by banding ligation and by injection sclerotherapy.  Gastrointest Endosc. 1999;  49 (4 Pt 1) 428-436
    CrossrefPubMedGoogle Scholar
  • 28 Wong R C, Farooq F T, Chak A. Endoscopic Doppler US probe for the diagnosis of gastric varices (with videos).  Gastrointest Endosc. 2007;  65 (3) 491-496
    CrossrefPubMedGoogle Scholar
  • 29 El-Saadany M, Jalil S, Irisawa A, Shibukawa G, Ohira H, Bhutani M S. EUS for portal hypertension: a comprehensive and critical appraisal of clinical and experimental indications.  Endoscopy. 2008;  40 (8) 690-696
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Lee Y T, Chan F K, Ng E K et al.. EUS-guided injection of cyanoacrylate for bleeding gastric varices.  Gastrointest Endosc. 2000;  52 (2) 168-174
    CrossrefPubMedGoogle Scholar
  • 31 Rajoriya N, Forrest E H, Gray J et al.. Long-term follow-up of endoscopic Histoacryl glue injection for the management of gastric variceal bleeding.  QJM. 2011;  104 (1) 41-47
    CrossrefPubMedGoogle Scholar
  • 32 Romero-Castro R, Pellicer-Bautista F, Giovannini M et al.. Endoscopic ultrasound (EUS)-guided coil embolization therapy in gastric varices.  Endoscopy. 2010;  42 (Suppl 2) E35-E36
    Article in Thieme ConnectPubMedGoogle Scholar
  • 33 Romero-Castro R, Pellicer-Bautista F J, Jimenez-Saenz M et al.. EUS-guided injection of cyanoacrylate in perforating feeding veins in gastric varices: results in 5 cases.  Gastrointest Endosc. 2007;  66 (2) 402-407
    CrossrefPubMedGoogle Scholar

Abdullah M. S. Al-OsaimiM.D. F.A.C.P. F.A.C.G. A.G.A.F. 

Associate Professor of Medicine and Surgery, Medical Director of Liver Transplantation, Division of Gastroenterology and Hepatology, Department of Medicine, University of Virginia Health System

Box 800708, 1215 Lee Street, Charlottesville, VA 22908

Email: aa6h@virginia.edu

      >